BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1661084)

  • 1. cAMP stimulates protein kinase C activity in cultured renal LLC-PK1 cells.
    Anderson RJ; Breckon R
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F945-50. PubMed ID: 1661084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine regulation of cyclic AMP metabolism in cultured renal epithelial LLC-PK1 cells.
    Dixon BS; Breckon R; Kaehny MM; Dillingham MA; Anderson RJ
    J Biol Chem; 1990 Jan; 265(2):760-6. PubMed ID: 1688553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation by forskolin of cyclic AMP phosphodiesterase and protein kinase C activity in LLC-PK1 cells.
    Anderson RJ; Breckon R; Colston D
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):23-7. PubMed ID: 1718261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta 1 regulation of signal transduction in two renal epithelial cell lines.
    Anderson RJ; Sponsel HT; Breckon R; Marcell T; Hoeffler JP
    Am J Physiol; 1993 Oct; 265(4 Pt 2):F584-91. PubMed ID: 8238388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP receptor regulation of adenylate cyclase and protein kinase C activity in cultured renal LLC-PK1 cells.
    Anderson RJ; Breckon R; Dixon BS
    J Clin Invest; 1991 May; 87(5):1732-8. PubMed ID: 1850760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
    Jans DA; Resink TJ; Hemmings BA
    Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C inhibits arginine vasopressin-stimulated cAMP accumulation via a Gi-dependent mechanism.
    Teitelbaum I
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F216-20. PubMed ID: 8383449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMA and staurosporine affect expression of the PCK gene in LLC-PK1-F+ cells.
    Liu W; Feifel E; Holcomb T; Liu X; Spitaler N; Gstraunthaler G; Curthoys NP
    Am J Physiol; 1998 Sep; 275(3):F361-9. PubMed ID: 9729508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing regulatory effects of protein kinase C on the cAMP cascade in human HL-60 promyelocytic leukemia cells.
    Byung-Chang S; Se-Young C; Jang-Soo C; Kyong-Tai K
    Eur J Pharmacol; 1998 Jul; 353(1):105-15. PubMed ID: 9721047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vasopressin-stimulated water flow in toad bladder by phorbol myristate acetate, dioctanoylglycerol, and RHC-80267. Evidence for modulation of action of vasopressin by protein kinase C.
    Schlondorff D; Levine SD
    J Clin Invest; 1985 Sep; 76(3):1071-8. PubMed ID: 2995443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the tumor promoter, phorbol 12-myristate, 13-acetate, on the epidermal adenylate cyclase system: evidence for adenylate cyclase-regulation by protein kinase C.
    Iizuka H; Sakai H; Tamura T
    J Invest Dermatol; 1989 Sep; 93(3):387-91. PubMed ID: 2549124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A induces phosphorylation of the human 5-HT1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells.
    Raymond JR; Olsen CL
    Biochemistry; 1994 Sep; 33(37):11264-9. PubMed ID: 7727377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional and post-transcriptional regulation of monocyte chemoattractant protein-3 gene expression in human endothelial cells by phorbol ester and cAMP signalling.
    Kondo A; Isaji S; Nishimura Y; Tanaka T
    Immunology; 2000 Apr; 99(4):561-8. PubMed ID: 10792504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway.
    Izumi Y; Nakayama Y; Mori T; Miyazaki H; Inoue H; Kohda Y; Inoue T; Nonoguchi H; Tomita K
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1418-26. PubMed ID: 17213462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modulation of the adenylate cyclase-cAMP pathway by protein kinase C in chick retinal pigment epithelium].
    Hirota A
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1412-7. PubMed ID: 1335681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV.
    Yamaki M; McIntyre S; Murphy JM; Swinnen JV; Conti M; Dousa TP
    Kidney Int; 1993 Jun; 43(6):1286-97. PubMed ID: 8391097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A; Knesel J; Fabbro D; Nagamine Y
    J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitative actions of the protein kinase-C effector system on hormonally stimulated adenosine 3',5'-monophosphate production by swine luteal cells.
    Wheeler MB; Veldhuis JD
    Endocrinology; 1989 Nov; 125(5):2414-20. PubMed ID: 2551649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
    Jans DA; Resink TJ; Hemmings BA
    Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by phorbol ester of cellular adenosine 3',5'-monophosphate production and cellular free calcium mobilization in response to arginine vasopressin in rat renal papillary collecting tubule cells in culture.
    Ishikawa S; Saito T
    Endocrinology; 1991 Feb; 128(2):786-91. PubMed ID: 1846589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.